Related Experiment Video
Updated: Mar 12, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Published on: May 25, 2020
Metabolic support for the heart: complementary therapy for heart failure?
Ward A Heggermont1,2,3, Anna-Pia Papageorgiou1,2, Stephane Heymans1,2
1Centre for Molecular and Vascular Biology, Department of Cardiovascular Research, University of Leuven, Belgium.
Heart failure increases energy needs while reducing efficiency. Therapies targeting cardiac metabolism could improve treatments for heart failure patients, complementing existing hemodynamic therapies.
Area of Science:
- Cardiology
- Metabolic Medicine
- Biochemistry
Background:
- Heart failure presents a dual challenge: elevated metabolic demand coupled with reduced energy efficiency.
- Metabolic dysfunction is well-documented in heart failure with reduced ejection fraction and increasingly recognized in heart failure with preserved ejection fraction.
Purpose of the Study:
- To review the fundamental aspects of normal cardiac metabolism.
- To outline the characteristic metabolic alterations observed in heart failure.
- To discuss established and emerging therapeutic strategies focused on modulating cardiac metabolism.
Main Methods:
- Literature review of cardiac metabolism in health and disease.
- Analysis of metabolic disturbances in various heart failure phenotypes.
- Examination of therapeutic targets influencing cardiac energy metabolism.
Main Results:
- Normal cardiac metabolism relies on efficient substrate utilization.
- Heart failure is characterized by significant metabolic reprogramming, impacting energy production.
- Current treatments primarily address hemodynamics, not the heart's energetic deficit.
Conclusions:
- Targeting cardiomyocyte metabolism offers a promising complementary approach to current heart failure therapies.
- Understanding and intervening in cardiac metabolic pathways are crucial for improving heart failure management.
- Further research into metabolic interventions is warranted for both reduced and preserved ejection fraction heart failure.
More Related Videos
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure VII: Nursing Interventions
Heart Failure II: Pathophysiology

